RxSight, Inc. Other Non-Current Assets
RxSight, Inc. (RXST) had Other Non-Current Assets of $1.02 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Assets, Noncurrent $1.02M.
- 2026-03-31: Other Assets, Noncurrent $1.03M.
- 2025-12-31: Other Assets, Noncurrent $590.00K.
- 2025-09-30: Other Assets, Noncurrent $536.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $1.02M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $1.03M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $590.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $536.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $542.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $401.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $360.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $213.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $303.00K 10-Q · filed 2024-08-05 |
| 2024-03-31 | $226.00K 10-Q · filed 2024-05-06 |
| 2023-12-31 | $147.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $137.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $348.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $746.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $767.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $782.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $188.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $132.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $114.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $287.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.34M 10-Q · filed 2021-09-09 |
| 2020-12-31 | $110.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |